Newshash
2026-06-12
Viewing archive: 2026-06-12 Back to today
← All stories

UK government launches one-off meningitis B vaccine programme for one million school leavers and new university students

Unbiased summary

The UK government has announced a one-off meningitis B vaccination programme targeting approximately one million young people: Year 13 pupils born between 1 September 2007 and 31 August 2008, and those under 25 entering university or residential further education for the first time this autumn, including international students. Two doses of the Bexsero vaccine will be offered, with the first available from 20 July and the second in August, at least 28 days apart. The programme follows an outbreak in Kent — described as the UK's largest and fastest-growing MenB outbreak — that killed two teenagers, plus additional clusters in Dorset and Berkshire resulting in a third death. Health Secretary James Murray cited a possible change in how MenB affects people as justification for acting ahead of peak disease season in October and November.

Coverage by outlet
The Guardian left
Angle Presents the programme as a measured, evidence-based public health response, emphasising scientific detail and government accountability.
Bias The Guardian provides the most comprehensive scientific context, including vaccine efficacy duration and the fact that different strains were involved across outbreaks. It accurately notes three deaths across all clusters, unlike some outlets that focus only on Kent. However, it buries the human impact entirely and includes an unrelated article prompt about youth unemployment, which dilutes the story's focus and is editorially anomalous.
The Mirror centre-left
Angle Humanises the story through the Juliette Kenny family's campaign, framing the programme as a response driven by grieving families and public pressure.
Bias The Mirror correctly notes two deaths in Kent but omits the third death from the Berkshire cluster, which the Guardian and Sun include. It gives prominent space to the Kenny family's campaigning, which, while factually accurate, frames the government's decision as reactive to public pressure rather than a proactive public health assessment. Practical details like the September catch-up option and pharmacy booking process are well covered.
BBC News centre-left
Angle Uses a detailed personal tragedy — the death of Aaron Mills in January 2026 — to illustrate the stakes and contextualise the vaccine gap.
Bias The BBC is the only outlet to feature Aaron Mills, who died of meningitis in January 2026, adding important human context but also introducing a case not directly cited in the government's announcement as a trigger for this specific programme. This risks implying a causal link that may not be explicit in the official rationale. The BBC also uniquely clarifies the distinction between MenB and MenACWY vaccines, which is valuable and missing from other outlets.
GB News right
Angle Focuses on the Juliette Kenny story and family campaigning, presenting the programme largely as a human-interest story with minimal policy analysis.
Bias GB News contains a factual error, stating international students 'have been encouraged to get the vaccine in their home countries,' whereas the Guardian explicitly states international students are included in the programme. It omits the Dorset and Berkshire clusters almost entirely and provides the least policy and scientific context of all outlets. The piece is shorter and more anecdote-driven, which limits its informational depth.
The Sun right
Angle Leads with a dramatic, consumer-focused angle emphasising deaths and urgency, presenting the programme as a direct governmental rescue response.
Bias The Sun's headline references 'thousands' of teens despite the body correctly stating one million, creating an inconsistency that understates the programme's scale. It incorrectly states three deaths occurred 'in Kent and Reading,' when in fact one death was in Berkshire and the Kent outbreak caused two deaths — the framing conflates the clusters. Practical information such as the September catch-up and pharmacy booking is included, but scientific nuance around strains and vaccine efficacy is largely absent.